JILLIAN GOLDNEY: Open Payments
NPI 1144733767 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 24 payments from 8 companies in 2025. Trend: 2023 $605 · 2024 $945 · 2025 $659
Food & beverage: $498Education: $161
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $236 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $169 |
| ABBVIE INC. | 3 | $79 |
| Amgen Inc. | 4 | $73 |
| GENZYME CORPORATION | 2 | $38 |
| PFIZER INC. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
Products named: TREMFYA, ILUMYA, OTEZLA, RINVOQ, DUPIXENT, SKYRIZI, CIBINQO, Sotyktu.
Industry payments across AZ — which companies pay providers there.
